|ClinWrite, Berlin, Germany (own business)||1998-present|
EMWA workshop leader for the training topic Clinical Study Design: basic and advanced courses and I lead a master class in Editing Documents Originating From Non-Native Speakers of English.
Customized training for groups and individual, coaching in scientific writing for non-native speakers utilizing documents authored by the participants.
|Head of Clinical Development Support, Therapeutics||Schering AG, Berlin, Germany||1994-1998|
Line Manager for all medical writers, CRAs and archive function. The position also included responsibility for outsourcing.
|Clinical project leader||Schering AG, Berlin, Germany||1978-1994|
Responsible for planning and leading the European Phase III and overseeing the reports and summary documents for the licensing application for an anxiolytic, in cooperation with a US American development partner.
Plan, conduct and report phase II and III for an antidepressant.
Plan, conduct and report Phase II and III and write submission dossiers for an oral, sublingual and iv formulated benzodiazepine in the indications insomnia and premed. for surgical procedures
|Scientist, CNS Phase I unit||Schering AG, Berlin, Germany||1974-1978|
Responsible for planning and conducting phase I studies in CNS and authoring review articles.
|BA Hons in Social Science (psychology specialty) York University, UK||1971-1974|
|MS in applied psychology, George Peabody College, Berlin subsidiary||1976-1977|
|Admission to the Freie Universität, Berlin as part-time doctoral student (dissertation not completed)||1979|